![Chemocentric Informatics Analysis: Dexamethasone Versus Combination Therapy for COVID-19 | ACS Omega Chemocentric Informatics Analysis: Dexamethasone Versus Combination Therapy for COVID-19 | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.0c03597/asset/images/large/ao0c03597_0009.jpeg)
Chemocentric Informatics Analysis: Dexamethasone Versus Combination Therapy for COVID-19 | ACS Omega
![Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 | University of Oxford Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 | University of Oxford](https://www.ox.ac.uk/sites/files/oxford/styles/ow_medium_feature/s3/field/field_image_main/thumbnail_BUDESONIDE_COMPOSITE.jpg?itok=5_9Ln01t)
Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 | University of Oxford
![SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol | For Health Care Professionals SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol | For Health Care Professionals](https://www.symbicorttouchpoints.com/content/dam/physician-services/us/526-rwd-symbicort-hcp/Desktop-images/symbicort-inhalers.png)
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol | For Health Care Professionals
![Viatris Announces Launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort® for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva Viatris Announces Launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort® for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva](https://mma.prnewswire.com/media/2165347/Viatris_Breyna.jpg?p=facebook)
Viatris Announces Launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort® for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva
![Asthma care in 2022: Symbicort Turbuhaler vs Rapihaler and tips for performing spirometry during the pandemic - North Western Melbourne Primary Health Network Asthma care in 2022: Symbicort Turbuhaler vs Rapihaler and tips for performing spirometry during the pandemic - North Western Melbourne Primary Health Network](https://nwmphn.org.au/wp-content/uploads/2022/08/Symbicort-turbuhaler.png)
Asthma care in 2022: Symbicort Turbuhaler vs Rapihaler and tips for performing spirometry during the pandemic - North Western Melbourne Primary Health Network
Inhaled corticosteroids to be investigated as a possible treatment for Covid-19 in national PRINCIPLE Trial — Nuffield Department of Primary Care Health Sciences, University of Oxford
![Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma | European Respiratory Society Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma | European Respiratory Society](https://erj.ersjournals.com/sites/default/files/highwire/erj/51/1.cover-source.jpg)